Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

A L Potts; K L Young; B S Carter; J P Shenai

doi:10.1038/sj.jp.7211640

Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

J Perinatol. 2007 Feb;27(2):120-2. doi: 10.1038/sj.jp.7211640.

Authors

A L Potts¹, K L Young, B S Carter, J P Shenai

Affiliation

¹ Department of Pharmacy, Vanderbilt Children's Hospital, Nashville, TN 37232-9544, USA.

PMID: 17262045
DOI: 10.1038/sj.jp.7211640

Abstract

A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.

MeSH terms

Citalopram / adverse effects*
Citalopram / therapeutic use
Enterocolitis, Necrotizing / chemically induced*
Female
Humans
Infant, Newborn
Milk, Human / drug effects*
Pregnancy
Pregnancy Complications / drug therapy*
Prenatal Exposure Delayed Effects / chemically induced*
Selective Serotonin Reuptake Inhibitors / adverse effects*
Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

Serotonin Uptake Inhibitors
Citalopram